IDEXX Laboratories Expands Fecal Antigen Testing Platform With Tapeworm Detection

MT Newswires Live05-26

IDEXX Laboratories (IDXX) said Tuesday it expanded its diagnostic testing platform to include the detection of taeniid tapeworm species.

The updated screening tool identifies intestinal parasite infections earlier than traditional methods and now identifies seven major intestinal parasite groups, including species that pose transmission risks to humans in the US, Canada, and Europe, the company said.

The diagnostic panels will automatically integrate the new tapeworm detection features at no additional charge for customers in the US and Canada starting in late June, IDEXX Laboratories said.

Shares of the company were up 1.7% in Tuesday premarket activity.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment